UK markets closed

Ocuphire Pharma, Inc. (R3X1.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
1.8180+0.1220 (+7.19%)
At close: 09:55PM CEST
Currency in EUR

Valuation measures4

Market cap (intra-day) 42.83M
Enterprise value 24.95M
Trailing P/E 1.70
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.06
Price/book (mrq)0.90
Enterprise value/revenue 1.31
Enterprise value/EBITDA -2.50

Trading information

Stock price history

Beta (5Y monthly) 0.24
52-week change 3-67.13%
S&P500 52-week change 322.38%
52-week high 36.0100
52-week low 31.3900
50-day moving average 31.8321
200-day moving average 32.6710

Share statistics

Avg vol (3-month) 3128
Avg vol (10-day) 3N/A
Shares outstanding 524.81M
Implied shares outstanding 627.13M
Float 823.83M
% held by insiders 16.51%
% held by institutions 113.57%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -52.42%
Operating margin (ttm)-321.05%

Management effectiveness

Return on assets (ttm)-12.83%
Return on equity (ttm)-20.77%

Income statement

Revenue (ttm)19.05M
Revenue per share (ttm)0.88
Quarterly revenue growth (yoy)-95.80%
Gross profit (ttm)N/A
EBITDA -10.56M
Net income avi to common (ttm)-9.99M
Diluted EPS (ttm)-0.4300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)50.52M
Total cash per share (mrq)2.04
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)13.35
Book value per share (mrq)2.08

Cash flow statement

Operating cash flow (ttm)-1.11M
Levered free cash flow (ttm)244.12k